NCT04681313Completed
Pressure-Volume Loop During High-Risk PCI
Pressure-Volume Loop During PCI: Real-Time Left Ventricular Pressure-Volume Analysis in High-Risk PCI
Source: ClinicalTrials.gov · Last updated 14 Nov 2024
Brief summary (registry, in English)
This study will examine the physiologic effects on loading conditions and contractility of the left ventricle during high-risk primary coronary intervention (HRPCI) in the Cardiac Cath Lab. This will be performed through analysis of real-time left ventricular (LV) pressure-volume loops (PVL) by continuously recording PVL during HRPCI with the Inca® Pressure-Volume Loop System that will be temporarily placed in the left ventricle during the procedure.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10 (actual)
- First submitted
- 18 Dec 2020
- Start date
- 19 Apr 2021
- Primary completion date
- 1 Dec 2022
- Lead sponsor
- Henry Ford Health System
- Diseases
- Coronary artery disease
- NCT number
- NCT04681313
What you commit to
- Study type: Observational
- Participants enrolled: 10
- From 19 Apr 2021 to the primary completion date, 1 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Any patient not considered appropriate for elective HRPCI procedures.
Who the study is looking for
- Adult patients (18 years and older) with known coronary artery disease and planned elective HRPCI procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Henry Ford Hospital Coordinator of this site? Confirm its status | Detroit | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.